NCT01158417View on ClinicalTrials.gov

Resveratrol in Type2 Diabetes and Obesity

NATerminatedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

July 8, 2012

Study Completion Date

July 8, 2012

Conditions

Type 2 DiabetesObesityInsulin Resistance

Interventions

DRUG

Placebo

oral

DRUG

Resveratrol 40 mg oral three times a day

Drug

DRUG

Resveratrol 500 mg oral once daily.

Resveratrol 500 mg oral once daily.

Trial Locations (1)

14221

Jeanne Hejna, Williamsville

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Kaleida Health

OTHER

lead

University at Buffalo

OTHER

NCT01158417 - Resveratrol in Type2 Diabetes and Obesity | Biotech Hunter | Biotech Hunter